Abstract: Fibrous structures that exhibit a Tensile Ratio of greater than 0.5 as measured according to the Tensile Strength Test Method described herein and a Geometric Mean Flexural Rigidity (GM Flexural Rigidity or GM Flex) of less than 195 mg*cm2/cm as measured according to the Flexural Rigidity Test Method described herein and/or a Geometric Mean Modulus (GM Modulus) of less than 935 g/cm and/or a Machine Direction Modulus (MD Modulus) of less than 845 g/cm, are provided.

Abstract: Fibrous structures that exhibit a Geometric Mean Flexural Rigidity (GM Flexural Rigidity or GMFlex) as measured according to the Flexural Rigidity Test Method described herein to Dry Burst (DB) as measured according to the Dry Burst Test Method described herein ratio (GMFlex/DB ratio) of less than 0.26 and a Density of less than 0.10 g/cm3 as measured according to the Test Methods described herein are provided.

Abstract: Fibrous structures that exhibit a Dry Burst of greater than 100 g and a Cross-Machine Direction Flexural Rigidity (CD Flexural Rigidity) of greater than 56 mg*cm2/cm as measured according to the Flexural Rigidity Test Method and/or a Total Dry Tensile (TT or TDT) of less than 3000 g/76.2 mm as measured according to the Tensile Strength Test Method and/or a Geometric Mean Tensile (GM Tensile or GMT) of less than 750 g/76.2 mm as measured according to the Tensile Strength Test Method and/or a Machine Direction Modulus (MD Modulus) of less than 900 g/cm as measured according to the Modulus Test Method are provided.

Abstract: Fibrous structures that exhibit a Geometric Mean Modulus (GM Modulus) of less than 1070 g/cm as measured according to the Modulus Test Method described herein and a Geometric Mean Elongation (GM Elongation or GM Elong) of less than 15% measured according to the Elongation Test Method described herein are provided.

Abstract: In one particular embodiment, the disclosure is directed to a network management system. The network monitoring system includes at least one device definition file, a simple network management protocol enabled communications interface, and a data access interface. The definition file includes query instructions associated with portions of MIBs associated with a network device. The simple network management protocol enabled communications interface may access the network device using the query instructions and may receive response data from the network device. The data access interface may be configured to provide external access to the response data and configure thresholds.

Abstract: In one particular embodiment, the disclosure is directed to a network management system. The network monitoring system includes at least one device definition file, a simple network management protocol enabled communications interface, and a data access interface. The definition file includes query instructions associated with portions of MIBs associated with a network device. The simple network management protocol enabled communications interface may access the network device using the query instructions and may receive response data from the network device. The data access interface may be configured to provide external access to the response data and configure thresholds.

Abstract: In one particular embodiment, the disclosure is directed to a network management system. The network monitoring system includes at least one device definition file, a simple network management protocol enabled communications interface, and a data access interface. The definition file includes query instructions associated with portions of MIBs associated with a network device. The simple network management protocol enabled communications interface may access the network device using the query instructions and may receive response data from the network device. The data access interface may be configured to provide external access to the response data and configure thresholds.

Abstract: The invention provides methods and compositions employing hybrid molecules of a synthetic molecule and antibody or antibody fragment comprising a selenocysteine residue, wherein the synthetic molecule is covalently linked to the antibody or antibody fragment at the selenocysteine residue. The invention also provides a composition comprising a hybrid molecule as described above and a pharmaceutically acceptable carrier. The invention further provides for methods of making the hybrid molecules, and methods of using the hybrid molecule described above to inhibit cell surface receptor binding.

Abstract: A multi-ply paper product having a first ply and a second ply. The first ply has a plurality of first surface features, the first surface features have a number density of from about 5/cm2 to about 20/cm2, a surface area of from about 0.3 mm2 to about 4 mm2, and a height of from about 600 microns to about 2500 microns. The second ply has a plurality of second surface features with a number density of from about 30/cm2 to about 80/cm2, a surface area of from about 0.03 mm2 to about 1.2 mm2, and a height of from about 400 microns to about 1600 microns.

Abstract: Provided are methods of simulating tissue healing. The methods comprise using a mechanistic computer model of the interrelated effects of inflammation, tissue damage or dysfunction and tissue healing to predict an outcome of healing of damaged tissue in vivo, thereby predicting the outcome of healing of damaged tissue in vivo. Implementations of these methods on a computing device also are provided. Non-limiting examples of diseases and/or conditions that are amenable to simulation according to the methods described herein include: a diabetes, diabetic foot ulcers, necrotizing enterocolitis, ulcerative colitis, Crohn's disease, inflammatory bowel disease, restenosis (post-angioplasty or stent implantation), incisional wounding, excisional wounding, surgery, accidental trauma, pressure ulcer, stasis ulcer, tendon rupture, vocal fold phonotrauma, otitis media and pancreatitis.

Abstract: A system and process for performing a crimping operation by which a fitting is crimped to the end of a fluid conduit, and which automatically compensates for one or more variables that can lead to out-of-tolerance crimp diameters, particularly fitting spring-back and crimper deflection. The system and method use a device for inputting into the system a targeted crimp diameter for the fitting, and a crimper for crimping the fitting to the end of the fluid conduit. The crimper comprises a plurality of dies and an actuator for contracting the dies around the fitting to obtain the targeted crimp diameter for the fitting. The system and method further includes a unit for attaining the targeted crimp diameter by automatically compensating contraction of the dies for spring-back of the fitting during crimping and/or deflection of the crimper during crimping.

Abstract: A toothpaste tube squeezing mechanism includes a housing in which a toothpaste tube is stored and a button which is pushed to dispense toothpaste from the tube. The button is connected to a tube squeezing mechanism by a gear system.

Abstract: In one particular embodiment, the disclosure is directed to a network management system. The network monitoring system includes at least one device definition file, a simple network management protocol enabled communications interface, and a data access interface. The definition file includes query instructions associated with portions of MIBs associated with a network device. The simple network management protocol enabled communications interface may access the network device using the query instructions and may receive response data from the network device. The data access interface may be configured to provide external access to the response data and configure thresholds.